These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 10487521)

  • 1. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
    Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
    Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical upregulation of tumor suppressor protein p53 in serum-stimulated vascular smooth muscle cells: a novel negative-feedback regulatory mechanism.
    Mnjoyan ZH; Dutta R; Zhang D; Teng BB; Fujise K
    Circulation; 2003 Jul; 108(4):464-71. PubMed ID: 12860918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis in breast cancer cells by TPA.
    Li Y; Bhuiyan M; Mohammad RM; Sarkar FH
    Oncogene; 1998 Dec; 17(22):2915-20. PubMed ID: 9879997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
    Shao ZM; Dawson MI; Li XS; Rishi AK; Sheikh MS; Han QX; Ordonez JV; Shroot B; Fontana JA
    Oncogene; 1995 Aug; 11(3):493-504. PubMed ID: 7630633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis.
    Allan LA; Fried M
    Oncogene; 1999 Sep; 18(39):5403-12. PubMed ID: 10498894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
    Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
    Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells.
    Harwood FG; Frazier MW; Krajewski S; Reed JC; Houghton JA
    Oncogene; 1996 May; 12(10):2057-67. PubMed ID: 8668331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
    Gottlieb E; Lindner S; Oren M
    Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity.
    Kawamura M; Yamashita T; Segawa K; Kaneuchi M; Shindoh M; Fujinaga K
    Oncogene; 1996 Jun; 12(11):2361-7. PubMed ID: 8649776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.